About Jeffrey Kim
Form D filings for Slingshot Biosciences from 2021 to 2024 list Jeffrey Kim as chief executive officer and director.
Jeffrey Kim first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Kim in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Kim works with at each company, as listed on that company's latest Form D.
Slingshot Biosciences, Inc. · Form D/A, Apr 26, 2024
NB
Nicolas Barthelemy
Director
PW
Patrick Weiss
Director
CR
Corey Ritter
Director
AL
Andrew Lee
Director
RS
Ronald Silberman
Director